AMPE
Income statement / Annual
Last year (2023), Ampio Pharmaceuticals, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Ampio Pharmaceuticals, Inc.'s net income was -$8.63 M.
See Ampio Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.16 M
|
$76,787.00
|
| Cost of Revenue |
$250,000.00 |
$2.08 M |
$1.09 M |
$1.18 M |
$1.27 M |
$523,000.00 |
$568,000.00 |
$950,000.00 |
$369,309.00 |
$2.24 M |
| Gross Profit |
-$250,000.00 |
-$2.08 M |
-$1.09 M |
-$1.18 M |
-$1.27 M |
-$523,000.00 |
-$568,000.00 |
-$950,000.00 |
$793,153.00 |
-$2.16 M |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.68 |
-28.18 |
| Research and Development
Expenses |
$2.44 M
|
$8.92 M
|
$11.90 M
|
$9.17 M
|
$12.62 M
|
$6.83 M
|
$10.42 M
|
$10.55 M
|
$18.96 M
|
$26.92 M
|
| General & Administrative
Expenses |
$7.08 M
|
$11.47 M
|
$8.67 M
|
$6.65 M
|
$5.90 M
|
$4.36 M
|
$5.14 M
|
$6.54 M
|
$15.14 M
|
$12.23 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$7.08 M
|
$11.47 M
|
$8.67 M
|
$6.65 M
|
$5.90 M
|
$4.36 M
|
$5.14 M
|
$6.54 M
|
$15.14 M
|
$12.23 M
|
| Other Expenses |
$0.00 |
$1.94 M |
$0.00 |
$12,000.00 |
$56,000.00 |
$0.00 |
$323,554.00 |
$143,802.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$9.27 M |
$20.38 M |
$20.57 M |
$15.83 M |
$18.58 M |
$11.18 M |
$15.56 M |
$17.08 M |
$34.10 M |
$39.15 M |
| Cost And Expenses |
$9.52 M |
$20.38 M |
$20.57 M |
$15.83 M |
$18.58 M |
$11.18 M |
$15.56 M |
$17.08 M |
$34.46 M |
$39.15 M |
| Interest Income |
$348,000.00 |
$220,000.00 |
$4,000.00 |
$12,000.00 |
$77,000.00 |
$5,000.00 |
$3,086.00 |
$23,479.00 |
$59,853.00 |
$22,263.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$77,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$127,000.00
|
$2.08 M
|
$1.09 M
|
$1.18 M
|
$1.27 M
|
$1.28 M
|
$1.21 M
|
$1.21 M
|
$1.14 M
|
$439,098.00
|
| EBITDA |
$0.00
|
-$18.30 M
|
$0.00
|
$0.00
|
-$17.30 M
|
$35.26 M
|
-$14.46 M
|
-$14.81 M
|
-$23.34 M
|
$0.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-27.6 |
-503.11 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-28.65
|
-508.83
|
| Total Other
Income/Expenses Net |
$886,000.00
|
$4.05 M
|
$3.50 M
|
-$60,000.00
|
$4.95 M
|
$45.17 M
|
-$36.22 M
|
-$2.08 M
|
-$412,071.00
|
-$7.60 M
|
| Income Before Tax |
-$8.63 M |
-$16.34 M |
-$17.08 M |
-$15.89 M |
-$13.63 M |
$33.99 M |
-$51.89 M |
-$19.16 M |
-$33.71 M |
-$39.05 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-29
|
-508.54
|
| Income Tax Expense |
$0.00 |
-$7.87 M |
-$4.59 M |
$604,000.00 |
-$4.95 M |
$45.17 M |
$36.33 M |
$1.04 M |
-$1.29 M |
-$923,523.00 |
| Net Income |
-$8.63 M |
-$8.47 M |
-$12.49 M |
-$16.50 M |
-$8.68 M |
$33.99 M |
-$51.89 M |
-$19.16 M |
-$32.01 M |
-$38.13 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-27.54 |
-496.51 |
| EPS |
-10.67 |
-11.24 |
-18.79 |
-28.63 |
-18.32 |
92.1 |
-239.13 |
-107.06 |
-184.7 |
-227.72 |
| EPS Diluted |
-10.66 |
-11.24 |
-18.59 |
-27.71 |
-18.32 |
91.9 |
-238.41 |
-106.91 |
-184.7 |
-227.72 |
| Weighted Average Shares
Out |
$809,000.00
|
$753,615.00
|
$664,330.00
|
$576,155.00
|
$474,026.00
|
$369,000.00
|
$217,000.00
|
$179,000.00
|
$173,306.00
|
$167,421.00
|
| Weighted Average Shares
Out Diluted |
$810,113.00
|
$753,619.00
|
$671,493.00
|
$595,407.00
|
$474,026.00
|
$369,805.00
|
$217,658.00
|
$179,244.00
|
$173,306.00
|
$167,421.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
